Crescent Biopharma (CBIO) Share-based Compensation Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Crescent Biopharma | 569.36 Mn | 380.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.57% |
| Dec 31, 2025 | 23.86% |
| Sep 30, 2025 | 3.28% |
| Jun 30, 2025 | 24.83% |
| Mar 31, 2025 | -7.57% |
| Dec 31, 2024 | -8.06% |
| Sep 30, 2024 | -46.59% |
| Jun 30, 2024 | -4.49% |
| Mar 31, 2024 | -2.92% |
| Dec 31, 2023 | -4.60% |
| Sep 30, 2023 | -5.39% |
| Jun 30, 2023 | -5.69% |
| Mar 31, 2023 | -4.85% |
| Dec 31, 2022 | -1.39% |
| Sep 30, 2022 | -1.03% |
| Jun 30, 2022 | -0.56% |
| Mar 31, 2022 | 5.10% |
| Dec 31, 2021 | 12.70% |
| Sep 30, 2021 | 16.56% |
| Jun 30, 2021 | 15.15% |
| Mar 31, 2021 | 17.28% |
| Dec 31, 2020 | 20.34% |
| Sep 30, 2020 | 21.71% |
| Jun 30, 2020 | 30.91% |
| Mar 31, 2020 | 25.40% |
| Dec 31, 2019 | 29.03% |
| Sep 30, 2019 | 29.15% |
| Jun 30, 2019 | 29.42% |
| Mar 31, 2019 | 36.45% |
| Dec 31, 2018 | 80.14% |
| Sep 30, 2018 | 51.36% |
| Jun 30, 2018 | 60.01% |
| Mar 31, 2018 | 59.52% |